Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07
  • 2025-06
  • 2025-05
  • 2025-04
  • Carbapenemase Gene Transmission in CREC in Guangdong

    2026-09-17

    Carbapenemase Gene Transmission in CREC in Guangdong

    Study Background and Research Question

    Carbapenem-resistant Enterobacter cloacae (CREC) is an important member of the carbapenem-resistant Enterobacteriaceae group because resistance can arise through mobile carbapenemase-encoding genes (CEGs), clonal expansion, or both. Carbapenemase production may compromise multiple beta-lactam options, while plasmid localization allows resistance determinants to move between bacterial cells. These features make CREC a surveillance problem that cannot be assessed solely through routine susceptibility testing.

    The reference study by Chen, Yan, and colleagues examined 54 CREC isolates collected from eight teaching hospitals in Guangdong Province, China, between December 2022 and June 2024. Its central question was not simply how frequently CEGs occurred, but where the genes were located, whether they could transfer, which mobile genetic elements accompanied them, and whether isolates with shared genotypes appeared across hospitals and clinical departments. The authors also considered the clinical distribution of CEG-positive isolates during a period shaped by the healthcare pressures associated with COVID-19, while acknowledging that the study was not designed as a before-and-after pandemic comparison. The complete study is available in BMC Microbiology.

    Key Innovation from the Reference Study

    The main innovation is the integration of several evidence layers into one CREC transmission framework. PCR established the presence of selected CEGs; plasmid elimination experiments helped distinguish plasmid-associated from chromosomal carriage; conjugation tested whether resistance determinants were transferable; mobile-element analysis examined genetic contexts; and ERIC-PCR with NTSYS analysis assessed relatedness among isolates. This combination moves beyond a prevalence survey toward a mechanistic epidemiology of resistance dissemination.

    The study is particularly informative because it separates horizontal mobility from possible vertical spread. A gene detected on a plasmid and successfully transferred to a recipient has a different epidemiological implication from the same gene confined to a chromosome within a single lineage. Conversely, repeated ERIC-PCR patterns found in different hospitals or departments suggest that clonal dissemination may also contribute. The resulting interpretation is more nuanced than attributing CREC expansion to one gene or one clone.

    Methods and Experimental Design Insights

    The investigators used a hospital-based collection of confirmed CREC isolates. The design paired molecular detection with functional and epidemiological testing, allowing the authors to relate genotype to resistance phenotype and transmission potential. The major experimental components are summarized below based on the reference study methods.

    Protocol Parameters

    • Clinical sampling: Analyze CREC isolates recovered across eight teaching hospitals during December 2022–June 2024; interpret department and specimen distributions as surveillance observations rather than population incidence estimates.
    • Plasmid localization: Apply variable-temperature sodium dodecyl sulfate plasmid elimination followed by PCR to compare CEG detection before and after plasmid curing. This approach supports plasmid-versus-chromosome assignment but does not provide the sequence resolution of complete genome assembly.
    • Resistance testing: Use broth microdilution to compare antimicrobial susceptibility between CEG-positive and CEG-negative groups. The study reported significant group differences for imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin, as described in the published results.
    • Conjugation testing: Perform plasmid-transfer experiments with PCR confirmation in transconjugants. This provides functional evidence of horizontal transfer rather than inferring mobility only from the presence of plasmid DNA.
    • Mobile-element analysis: Screen for six mobile genetic element types, including ISEcp1, to identify genetic contexts associated with CEG carriage. A positive association should be interpreted as linkage evidence, not proof that one element alone caused transfer.
    • Strain relatedness: Use ERIC-PCR and NTSYS software to classify isolates into genotypes and calculate Dice similarity. This is useful for regional screening, although whole-genome sequencing would offer finer discrimination.

    Methodologically, the study illustrates why no single assay is sufficient. PCR can detect a resistance gene but cannot establish whether it is active, transferable, or linked to a particular plasmid. Conjugation adds a functional dimension, while ERIC-PCR adds a population structure dimension. Together, these methods provide a practical framework for laboratories that may not have immediate access to long-read sequencing or comprehensive genomic surveillance.

    Core Findings and Why They Matter

    CEGs were detected in 46 of 54 isolates, corresponding to 85.19% of the collection. The distribution was dominated by blaNDM-1: 18 isolates carried blaNDM-1 on both chromosomes and plasmids, while 25 carried it exclusively on plasmids. Two isolates carried only plasmid-associated blaIMP, and one carried both plasmid-associated blaNDM-1 and blaKPC-2. These findings indicate that blaNDM-1 was not confined to one genetic compartment and that plasmid carriage was especially common. The gene-localization results are reported in the reference article.

    The transfer experiments provided an important functional result. CEG transfer succeeded for 44 of 46 CEG-positive isolates, or 95.65%. Transfer success was 42 of 44 for blaNDM-1, 2 of 2 for blaIMP, and 0 of 1 for blaKPC-2. Although these proportions should not be generalized beyond the tested isolates, they demonstrate a high horizontal-transfer potential for the blaNDM-1-bearing elements examined in this collection. In practical terms, a plasmid-associated carbapenemase is not only a marker of resistance in the source strain; it may also represent a route for acquisition by other Enterobacterales.

    CEG-positive isolates showed significantly higher resistance rates than the CEG-negative group for imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin. This pattern supports the interpretation that carbapenemase carriage was associated with a broader multidrug-resistant phenotype, although resistance to non-carbapenem agents may also involve porin changes, efflux, target mutations, or additional beta-lactamases. Therefore, CEG detection should complement, rather than replace, phenotypic antimicrobial susceptibility testing.

    Mobile-element profiling identified six element types, with ISEcp1 reported in 47 of 54 isolates, or 87.04%. The most frequent pattern included four mobile genetic element types simultaneously, observed in 22 isolates, or 40.74%. These data point to a highly modular resistance environment in which multiple recombination or mobilization contexts may coexist. The findings do not establish a single universal transfer mechanism, but they do support intensified plasmid and mobile-element surveillance.

    ERIC-PCR divided the 54 isolates into 17 genotypes. Types E and G were each represented by 11 isolates, or 20.37%, and isolates in these groups originated from different departments across five hospitals. Two type E isolates shared a Dice coefficient of 100%. This pattern is compatible with both local clonal persistence and interdepartmental or interhospital dissemination, but it should not be interpreted as direct proof of a transmission chain without patient-level epidemiology and genome sequencing.

    The clinical distribution also provides useful targeting information. CEG-positive isolates were most frequently recovered from men, elderly patients, respiratory medicine, and sputum specimens, accounting for 35, 39, 11, and 18 of the 54 isolates, respectively. These observations can help laboratories prioritize respiratory-care settings and high-risk patient groups for screening, but they do not establish independent risk factors because the study did not report a multivariable analysis of the underlying patient population.

    Comparison with Existing Internal Articles

    The internal article Transmission Dynamics of Carbapenemase Genes in CREC in China summarizes the same study’s emphasis on blaNDM-1, multidrug resistance, and mobile gene dissemination. The reference paper adds the detailed experimental basis: gene localization, conjugation outcomes, mobile-element frequencies, and ERIC-PCR clustering. Thus, the internal overview is useful for rapid orientation, whereas the primary article should be used for numerical interpretation and methodological limitations.

    A second related resource, Transmission Dynamics of Carbapenemase Genes in CREC: Insights from Guangdong Hospitals, frames the findings around surveillance and laboratory assay development. That perspective is consistent with the paper’s practical value, but the study does not validate a new diagnostic platform or establish a predictive transmission model. Its strongest contribution is the coordinated characterization of resistance genes, genetic carriers, transferability, and strain relatedness in a defined multicenter collection.

    Limitations and Transferability

    Several limitations affect how the findings should be applied. First, the sample included 54 isolates from eight teaching hospitals and may not represent all hospitals, community settings, or geographic regions in China. Second, the cross-sectional collection cannot determine temporal changes in transmission or prove that COVID-19-related healthcare disruption caused the observed resistance pattern. Third, PCR and plasmid-curing experiments provide useful localization evidence but do not replace complete plasmid sequencing. The exact replicon types, accessory resistance genes, insertion junctions, and genomic backgrounds remain incompletely resolved.

    Fourth, conjugation success depends on laboratory conditions, donor and recipient strains, and selection procedures. High transfer rates in vitro should therefore be treated as evidence of capacity, not as a direct estimate of transmission frequency in patients. Fifth, ERIC-PCR can identify related profiles but has lower resolution and reproducibility than whole-genome sequencing. Finally, the clinical subgroup frequencies are descriptive. They can guide hypothesis generation and infection-control sampling, but prospective patient-level studies are needed to identify independent predictors and reconstruct transmission pathways.

    Despite these constraints, the study is transferable as a surveillance blueprint. Laboratories can combine CEG PCR with phenotypic testing, plasmid mobility assessment, mobile-element screening, and strain relatedness analysis. Where resources permit, short- and long-read sequencing would extend this framework by resolving plasmid architecture and confirming whether apparently related isolates share the same resistance element.

    Research Support Resources

    For researchers extending the susceptibility or antibacterial mechanism arm of this work, Levofloxacin (SKU B1959) is a synthetic fluoroquinolone antibiotic and DNA gyrase inhibitor that can support studies involving the bacterial DNA replication pathway. It should be used as a research reagent and comparator within validated antimicrobial susceptibility or mechanism-focused workflows, not as a substitute for CEG detection, plasmid localization, conjugation, or genomic surveillance.

    Why this cross-domain matters, maturity, and limitations

    The product information also describes separate research contexts, including an osteoblast growth inhibition assay, calcium deposition inhibition, and a chondrocyte glycosaminoglycan synthesis study. These cell and cartilage models are mechanistically distinct from CREC plasmid transfer and were not evaluated in the reference paper. They may be useful for parallel compound-characterization programs, but results from those systems should not be used to infer antibacterial efficacy, clinical treatment outcomes, or carbapenemase transmission control.